RESOLUTION OF DISAGREEMENTS CONCERNING DATA USED TO DETERMINE REFUNDS. In the case of a Manufacturer disputing the accuracy of DHA’s utilization data, the refund obligation as to the amount in dispute will be deferred pending good faith efforts to resolve the dispute in accordance with the procedures laid out below. Disputes must be submitted no later than seventy (70) days following the date of the release of the utilization data; the same date that payment is due. Please refer to the Information for Pharmaceutical Manufacturer’s webpage for Refund Payment Due and Dispute Cut-Off Dates. When the dispute is resolved, any refund owed relating to the amount in dispute will be due with interest from the date of the demand letter, consistent with 32 C.F.R. § 199.11, and will be paid by the Manufacturer or credited by DHA by the due date of the next quarterly payment after resolution.
RESOLUTION OF DISAGREEMENTS CONCERNING DATA USED TO DETERMINE REFUNDS. If the Company disputes the accuracy of the utilization data, the refund obligation as to the amount in dispute will be deferred pending good faith efforts to resolve the dispute in accordance with procedures established by the Director, DHA. When the dispute is resolved, any refund owed relating to the amount in dispute will be subject to interest, penalties, and fees from the date payment of the amount was initially due, consistent with 199.11 See 32 C.F. R. §199.21(q)(3)(iv).
